Bridgeway Capital Management’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,500
| Closed | -$62.9K | – | 1228 |
|
|
2024
Q3 | $62.9K | Hold |
12,500
| – | – | ﹤0.01% | 1199 |
|
|
2024
Q2 | $51.4K | Hold |
12,500
| – | – | ﹤0.01% | 1215 |
|
|
2024
Q1 | $95K | Hold |
12,500
| – | – | ﹤0.01% | 1212 |
|
|
2023
Q4 | $104K | Hold |
12,500
| – | – | ﹤0.01% | 1232 |
|
|
2023
Q3 | $106K | Hold |
12,500
| – | – | ﹤0.01% | 1222 |
|
|
2023
Q2 | $119K | Sell |
12,500
-5,000
| -29% | -$47.5K | ﹤0.01% | 1230 |
|
|
2023
Q1 | $102K | Hold |
17,500
| – | – | ﹤0.01% | 1236 |
|
|
2022
Q4 | $142K | Hold |
17,500
| – | – | ﹤0.01% | 1158 |
|
|
2022
Q3 | $161K | Buy |
17,500
+10,000
| +133% | +$92K | ﹤0.01% | 1177 |
|
|
2022
Q2 | $86K | Sell |
7,500
-5,000
| -40% | -$57.3K | ﹤0.01% | 1244 |
|
|
2022
Q1 | $265K | Buy |
+12,500
| New | +$265K | 0.01% | 1113 |
|